Pages

▼
Showing posts with label cancer drugs. Show all posts
Showing posts with label cancer drugs. Show all posts
Nov 7, 2015

Clinical Trials, Big Pharma, the FDA, and Expen$ive Drugs

›
...turns out this is not always a great combination for patients   Many of us, including this author, are taking one or more of the ne...
Apr 3, 2013

Myths and truths about cancer clinical trials

›
Myth #1 —Cures already exist for many cancers but drug companies are keeping them under wraps in order to make even higher profits when th...
Feb 23, 2013

What process does the FDA follow when determining whether to approve a drug?

›
FDA approval doesn’t actually take as long as most people think.  In a recent blog post, http://www.cancer-clinical-trials.com/201...
Jan 21, 2013

How does the FDA know about new side effects for a drug that has already been approved?

›
The FDA has surveillance programs in place to monitor the safety of drugs after approval.  These programs primarily rely on physic...
Dec 19, 2012

What metrics are typically used to determine if the drug is successful?

›
The ultimate success of a new drug or drug combination is judged by the “safe and effective” standard.  Both of course are examine...
Aug 19, 2012

Some Clinical Trials Can’t Recruit Enough Participants

›
Does that surprise you? In fact, participation in cancer clinical trials is very low. The National Cancer Institute (NCI) reports that only...
May 25, 2012

Cancer Drug Side effects: Are you getting the whole story?

›
In a word (or two), maybe yes and maybe no.   Lists of side effects are easy to find.   Every drug has them.   These lists may be ...
3 comments:
May 20, 2012

Answers to questions you always wanted ask - an interview with Dr. Barken

›
Dr. Israel Barken runs a wonderful site called Ask Dr. Barken .  He was kind enough to interview Dr. Beer about clinical trials.  This was...
1 comment:
Feb 15, 2012

Tom and Larry interviewed on the radio! Listen on Saturday the 18th

›
Larry and I got a chance to sit down with a radio reporter for an extended conversation about cancer clinical trials.  I biked in the rain...
1 comment: